Raymond James Reiterates Strong Buy Rating on ARS Pharmaceuticals Inc (SPRY), PT $32
Tweet Send to a Friend
Raymond James analyst Ryan Deschner reiterated a Strong Buy rating and $32.00 price target on ARS Pharmaceuticals Inc (NASDAQ: SPRY)The ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
